4//SEC Filing
Powl Brian T. 4
Accession 0001209191-23-041611
CIK 0001434316other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 5:19 PM ET
Size
5.5 KB
Accession
0001209191-23-041611
Insider Transaction Report
Form 4
Powl Brian T.
Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-07-05$4.87/sh−3,854$18,769→ 41,146 total
Footnotes (2)
- [F1]Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 11,250 shares of Common Stock underlying RSUs granted to the Reporting Person on June 27, 2022. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through "sell to cover" transactions and do not represent discretionary trades by the Reporting Person.
- [F2]Represents the weighted average sale price of the shares sold from $4.82 to $4.94 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth this footnote.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001934232
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 5:19 PM ET
- Size
- 5.5 KB